These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 24280982)

  • 1. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
    Ruderfer DM; Fanous AH; Ripke S; McQuillin A; Amdur RL; ; ; ; Gejman PV; O'Donovan MC; Andreassen OA; Djurovic S; Hultman CM; Kelsoe JR; Jamain S; Landén M; Leboyer M; Nimgaonkar V; Nurnberger J; Smoller JW; Craddock N; Corvin A; Sullivan PF; Holmans P; Sklar P; Kendler KS
    Mol Psychiatry; 2014 Sep; 19(9):1017-1024. PubMed ID: 24280982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder.
    Corponi F; Bonassi S; Vieta E; Albani D; Frustaci A; Ducci G; Landi S; Boccia S; Serretti A; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():23-29. PubMed ID: 30149091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.
    ; Amare AT; Schubert KO; Hou L; Clark SR; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Brichant-Petitjean C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Dayer A; Del Zompo M; DePaulo JR; Étain B; Falkai P; Forstner AJ; Frisen L; Frye MA; Fullerton JM; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Hofmann A; Jamain S; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Kliwicki S; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Ösby U; Pfennig A; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Volkert J; Witt S; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Baune BT
    JAMA Psychiatry; 2018 Jan; 75(1):65-74. PubMed ID: 29121268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes.
    ;
    Cell; 2018 Jun; 173(7):1705-1715.e16. PubMed ID: 29906448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
    Cross-Disorder Group of the Psychiatric Genomics Consortium
    Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
    Li Z; Li D; Chen X
    J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
    Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Schumacher J; Streit F; Meier S; Herms S; Hoffmann P; Lacour A; Witt SH; Reif A; Müller-Myhsok B; Lucae S; Maier W; Schwarz M; Vedder H; Kammerer-Ciernioch J; Pfennig A; Bauer M; Hautzinger M; Moebus S; Schenk LM; Fischer SB; Sivalingam S; Czerski PM; Hauser J; Lissowska J; Szeszenia-Dabrowska N; Brennan P; McKay JD; Wright A; Mitchell PB; Fullerton JM; Schofield PR; Montgomery GW; Medland SE; Gordon SD; Martin NG; Krasnov V; Chuchalin A; Babadjanova G; Pantelejeva G; Abramova LI; Tiganov AS; Polonikov A; Khusnutdinova E; Alda M; Cruceanu C; Rouleau GA; Turecki G; Laprise C; Rivas F; Mayoral F; Kogevinas M; Grigoroiu-Serbanescu M; Becker T; Schulze TG; Rietschel M; Cichon S; Fier H; Nöthen MM
    PLoS One; 2017; 12(2):e0171595. PubMed ID: 28166306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
    Ikeda M; Takahashi A; Kamatani Y; Momozawa Y; Saito T; Kondo K; Shimasaki A; Kawase K; Sakusabe T; Iwayama Y; Toyota T; Wakuda T; Kikuchi M; Kanahara N; Yamamori H; Yasuda Y; Watanabe Y; Hoya S; Aleksic B; Kushima I; Arai H; Takaki M; Hattori K; Kunugi H; Okahisa Y; Ohnuma T; Ozaki N; Someya T; Hashimoto R; Yoshikawa T; Kubo M; Iwata N
    Schizophr Bull; 2019 Jun; 45(4):824-834. PubMed ID: 30285260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.
    Psychiatric GWAS Consortium Bipolar Disorder Working Group
    Nat Genet; 2011 Sep; 43(10):977-83. PubMed ID: 21926972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci.
    Wiström ED; O'Connell KS; Karadag N; Bahrami S; Hindley GFL; Lin A; Cheng W; Steen NE; Shadrin A; Frei O; Djurovic S; Dale AM; Andreassen OA; Smeland OB
    Addiction; 2022 Mar; 117(3):600-610. PubMed ID: 34472679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression.
    Holen B; Shadrin AA; Icick R; Filiz TT; Hindley G; Rødevand L; O'Connell KS; Hagen E; Frei O; Bahrami S; Cheng W; Parker N; Tesfaye M; Jahołkowski P; Karadag N; Dale AM; Djurovic S; Smeland OB; Andreassen OA
    Addict Biol; 2023 Jun; 28(6):e13282. PubMed ID: 37252880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries.
    Williams HJ; Craddock N; Russo G; Hamshere ML; Moskvina V; Dwyer S; Smith RL; Green E; Grozeva D; Holmans P; Owen MJ; O'Donovan MC
    Hum Mol Genet; 2011 Jan; 20(2):387-91. PubMed ID: 21037240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits.
    So HC; Chau KL; Ao FK; Mo CH; Sham PC
    Psychol Med; 2019 Jun; 49(8):1286-1298. PubMed ID: 30045777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain.
    Ivorra JL; Rivero O; Costas J; Iniesta R; Arrojo M; Ramos-Ríos R; Carracedo A; Palomo T; Rodriguez-Jimenez R; Cervilla J; Gutiérrez B; Molina E; Arango C; Alvarez M; Pascual JC; Pérez V; Saiz PA; García-Portilla MP; Bobes J; González-Pinto A; Zorrilla I; Haro JM; Bernardo M; Baca-García E; González JC; Hoenicka J; Moltó MD; Sanjuán J
    Schizophr Res; 2014 Oct; 159(1):107-13. PubMed ID: 25124521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis between suicidal behaviour and candidate genes of bipolar disorder and schizophrenia.
    Finseth PI; Sønderby IE; Djurovic S; Agartz I; Malt UF; Melle I; Morken G; Andreassen OA; Vaaler AE; Tesli M
    J Affect Disord; 2014 Jul; 163():110-4. PubMed ID: 24461634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
    Bergen SE; O'Dushlaine CT; Ripke S; Lee PH; Ruderfer DM; Akterin S; Moran JL; Chambert KD; Handsaker RE; Backlund L; Ösby U; McCarroll S; Landen M; Scolnick EM; Magnusson PK; Lichtenstein P; Hultman CM; Purcell SM; Sklar P; Sullivan PF
    Mol Psychiatry; 2012 Sep; 17(9):880-6. PubMed ID: 22688191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
    Smeland OB; Bahrami S; Frei O; Shadrin A; O'Connell K; Savage J; Watanabe K; Krull F; Bettella F; Steen NE; Ueland T; Posthuma D; Djurovic S; Dale AM; Andreassen OA
    Mol Psychiatry; 2020 Apr; 25(4):844-853. PubMed ID: 30610197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder.
    Zhang Q; Shen Q; Xu Z; Chen M; Cheng L; Zhai J; Gu H; Bao X; Chen X; Wang K; Deng X; Ji F; Liu C; Li J; Dong Q; Chen C
    Neuropsychopharmacology; 2012 Feb; 37(3):677-84. PubMed ID: 22012475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shared genetic architecture of schizophrenia, bipolar disorder and lifespan.
    Muntané G; Farré X; Bosch E; Martorell L; Navarro A; Vilella E
    Hum Genet; 2021 Mar; 140(3):441-455. PubMed ID: 32772156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review.
    Gurung R; Prata DP
    Psychol Med; 2015; 45(12):2461-80. PubMed ID: 25858580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.